57 related articles for article (PubMed ID: 33719266)
1. [Effects of miR-203a targeting and its target gene on lymph node metastasis of breast cancer].
Han LR; Song JQ; Guo FB; Zhang DW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):600-604. PubMed ID: 33719266
[No Abstract] [Full Text] [Related]
2. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer.
Qasemi Rad M; Pouresmaeil V; Hosseini Mojahed F; Amirabadi A; Aalami AH
Mol Biol Rep; 2022 Jul; 49(7):6975-6985. PubMed ID: 35511316
[TBL] [Abstract][Full Text] [Related]
3. microRNAs Regulate Survivin in Colorectal Cancer Patients.
Chavoshi H; Bornehdeli S; Asadi M; Dolatkhah R; Caner A; Raeisi M
Adv Biomed Res; 2023; 12():227. PubMed ID: 38073748
[TBL] [Abstract][Full Text] [Related]
4. miR-203a-A multifaceted regulator modulating cancer hallmarks and therapy response.
Biswal P; Lalruatfela A; Behera SK; Biswal S; Mallick B
IUBMB Life; 2024 Mar; 76(3):108-124. PubMed ID: 37792370
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Changes in Pro-Oncogenic and Tumor-Suppressing MicroRNA in the Regional Lymph Node during Photodynamic Therapy of Experimental Breast Cancer.
Kabakov AV; Kazakov OV; Poveshchenko AF; Cherkas VN
Bull Exp Biol Med; 2024 Feb; 176(4):491-494. PubMed ID: 38492110
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED ARTICLE: Identification of microRNAs (miR-203/miR-7) as potential markers for the early detection of lymph node metastases in patients with cervical cancer.
Seifoleslami M; Khameneie MK; Mashayekhi F; Sedaghati F; Ziari K; Mansouri K; Safari A
Tumour Biol; 2015 Oct; ():. PubMed ID: 26490989
[No Abstract] [Full Text] [Related]
7. Retraction Note: Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis.
Peng M; Yang D; Hou Y; Liu S; Zhao M; Qin Y; Chen R; Teng Y; Liu M
Cell Death Dis; 2023 Sep; 14(9):640. PubMed ID: 37770443
[No Abstract] [Full Text] [Related]
8. [Effects of Toosendanin on the formation of CTPS cytoophidium in human gastric cancer cell MKN-45 and its mechanism].
Chen W; Zhang WW; Pan Y; Liu C; Shao SL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):633-636. PubMed ID: 33719272
[No Abstract] [Full Text] [Related]
9. MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR-PI3K/Akt/mTOR signaling pathway.
Cai G; Wang Y; Houda T; Yang C; Wang L; Gu M; Mueck A; Croteau S; Ruan X; Hardy P
Transl Oncol; 2021 Jun; 14(6):101068. PubMed ID: 33730679
[TBL] [Abstract][Full Text] [Related]
10. ACK1 is dispensable for development, skin tumor formation, and breast cancer cell proliferation.
Brandao R; Kwa MQ; Yarden Y; Brakebusch C
FEBS Open Bio; 2021 Jun; 11(6):1579-1592. PubMed ID: 33730447
[TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen-, progesterone-, and androgen-responsive genes in MCF-7 and MDA-MB-231 cells treated with o,p'-DDT, p,p'-DDT, or endosulfan.
Kalinina TS; Kononchuk VV; Gulyaeva LF
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-8. PubMed ID: 33728745
[TBL] [Abstract][Full Text] [Related]
12. Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
Surette A; Yoo BH; Younis T; Matheson K; Rameh T; Snowdon J; Bethune G; Rosen KV
Breast Cancer Res Treat; 2021 Jun; 187(3):743-758. PubMed ID: 33728523
[TBL] [Abstract][Full Text] [Related]
13. Role of Src/FAK in migration and invasion mediated by extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid.
Ramirez-Ricardo J; Leal-Orta E; Garcia-Hernandez A; Diaz-Aragon R; Cortes-Reynosa P; Thompson-Bonilla R; Salazar EP
Med Oncol; 2021 Mar; 38(4):40. PubMed ID: 33728516
[TBL] [Abstract][Full Text] [Related]
14. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.
Ng CCY; Md Nasir ND; Loke BN; Tay TKY; Thike AA; Rajasegaran V; Liu W; Lee JY; Guan P; Lim AH; Chang KTE; Gudi MA; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Yip GWC; Bay BH; Tan P; Teh BT; Tan PH
Mod Pathol; 2021 Jul; 34(7):1320-1332. PubMed ID: 33727697
[TBL] [Abstract][Full Text] [Related]
15. Brain metastasis with subtype conversion in a patient with male breast cancer: A case report.
Oh BH; Woo CG; Lee YJ; Park YS
Medicine (Baltimore); 2021 Mar; 100(11):e24373. PubMed ID: 33725931
[TBL] [Abstract][Full Text] [Related]
16. Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study.
Cortellini A; Cannita K; Tiseo M; Cortinovis DL; Aerts JGJV; Baldessari C; Giusti R; Ferrara MG; D'Argento E; Grossi F; Guida A; Berardi R; Morabito A; Genova C; Antonuzzo L; Mazzoni F; De Toma A; Signorelli D; Gelibter A; Targato G; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; Mansueto G; Zoratto F; Filetti M; Bracarda S; Citarella F; Russano M; Cantini L; Nigro O; Buti S; Minuti G; Landi L; Ricciardi S; Migliorino MR; Natalizio S; Simona C; De Filippis M; Metro G; Adamo V; Russo A; Spinelli GP; Di Maio M; Banna GL; Friedlaender A; Addeo A; Pinato DJ; Ficorella C; Porzio G
Eur J Cancer; 2021 May; 148():24-35. PubMed ID: 33721704
[TBL] [Abstract][Full Text] [Related]
17. Combretastatin A4-derived payloads for antibody-drug conjugates.
Huang R; Sheng Y; Xu Z; Wei D; Song X; Jiang B; Chen H
Eur J Med Chem; 2021 Apr; 216():113355. PubMed ID: 33721668
[TBL] [Abstract][Full Text] [Related]
18. Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.
Cascone T; Sacks RL; Subbiah IM; Drobnitzky N; Piha-Paul SA; Hong DS; Hess KR; Amini B; Bhatt T; Fu S; Naing A; Janku F; Karp D; Falchook GS; Conley AP; Sherman SI; Meric-Bernstam F; Ryan AJ; Heymach JV; Subbiah V
ESMO Open; 2021 Apr; 6(2):100079. PubMed ID: 33721621
[TBL] [Abstract][Full Text] [Related]
19. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
[TBL] [Abstract][Full Text] [Related]
20. Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Liu J; Itchins M; Nagrial A; Cooper WA; De Silva M; Barnet M; Varikatt W; Sivasubramaniam V; Davis A; Gill AJ; Blinman P; Lee K; Hui R; Gao B; Pavlakis N; Clarke S; Lee J; Boyer M; Kao S
Lung Cancer; 2021 May; 155():28-33. PubMed ID: 33721613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
